Invesco’s BioAge Labs BIOA Stock Holding History

Invesco’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.08M	Sell	176,110 -52,563	-23%	-$1.01M	﹤0.01%	2369
2025 Q4	$3.03M	Buy	+228,673	New	+$2.03M	﹤0.01%	2449

Other funds holding BIOA

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Invesco's BIOA Position: Q1 2026 in Review

Invesco reduced its BioAge Labs (BIOA) stake by 23% in Q1 2026, selling an estimated $1.01M and leaving 176,110 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #2369.

Invesco first reported a position in BIOA in Q4 2025 and has held it in 2 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

Invesco held 176,110 shares of BioAge Labs worth $3.08M as of Q1 2026.
Invesco sold 52,563 BioAge Labs shares in Q1 2026, an estimated $1.01M.
BioAge Labs made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #2369 holding.
Invesco first reported a position in BioAge Labs in Q4 2025 and has held it in 2 quarters since.
144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.